1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Characterization of the RAD52 Gene in the Budding Yeast Naumovozyma castellii
(
- Contribution to journal › Article
- 2022
-
Mark
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia : Results from the HEAT-AML trial
(
- Contribution to journal › Article
- 2015
-
Mark
Evolving Therapeutic Options for Polycythemia Vera : Perspectives of the Canadian Myeloproliferative Neoplasms Group
(
- Contribution to journal › Debate/Note/Editorial
- 2004
-
Mark
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival
(
- Contribution to journal › Article